Invention Grant
- Patent Title: Targeted binding agents against B7-H1
-
Application No.: US16519614Application Date: 2019-07-23
-
Publication No.: US11518809B2Publication Date: 2022-12-06
- Inventor: Christophe Queva , Michelle Morrow , Scott Hammond , Marat Alimzhanov , John Babcock , Ian Foltz , Jaspal Singh Kang , Laura Sekirov , Melanie Boyle , Matthieu Chodorge , Ross A. Stewart , Kathleen Ann Mulgrew
- Applicant: MEDIMMUNE LIMITED
- Applicant Address: GB Cambridge
- Assignee: MEDIMMUNE LIMITED
- Current Assignee: MEDIMMUNE LIMITED
- Current Assignee Address: GB Cambridge
- Agency: McDonnell Boehnen Hulbert and Berghoff LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00
Abstract:
Human monoclonal antibodies directed against B7-H1 and uses of these antibodies in diagnostics and for the treatment of diseases associated with the activity and/or expression of B7-H1 are disclosed. Additionally, hybridomas or other cell lines expressing such antibodies are disclosed.
Public/Granted literature
- US20210017282A1 TARGETED BINDING AGENTS AGAINST B7-H1 Public/Granted day:2021-01-21
Information query
